Summit Global Investments Enanta Pharmaceuticals Inc Transaction History

Summit Global Investments

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$65.41 - $84.65 $431,706 - $558,690	-6,600 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$85.46 - $126.37 $42,730 - $63,185	500 Added 8.2%	6,600 $564,000
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $499,284 - $735,111	6,100 New	6,100 $707,000

107

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $122M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.